Abstract Tumor-associated macrophages (TAMs), one of the most abundant immune cell
types in the tumor microenvironment (TME), account for approximately 50% of the local …

An emerging role of long non-coding RNAs (lncRNAs) in tumor progression has been
revealed in the last decade. Through interactions with nucleic acids and proteins, lncRNAs …

Background Some long non-coding RNAs (lncRNAs) have been found to contribute to
cisplatin resistance. Here, we identified a novel lncRNA that was downregulated in cisplatin …

Ovarian cancer is one of the most lethal gynecological malignancies worldwide because it
tends to be detected late, when the disease has already spread, and prognosis is poor. In …

Objectives The current study aimed to investigate the potentiality of three lncRNAs
“Plasmacytoma variant translocation 1 (lnc-PVT1), Taurine upregulated gene type 1 (lnc …

Exosomes are a class of small extracellular vesicles, 30-150 nm in diameter, that transfer
biological information (eg, DNA, RNA, and protein) via cell-to-cell communication …

Nearly 70% of ovarian cancer (OC) patients experience recurrence within the first 2 years
after initial treatment. Emerging evidence indicates that long non-coding RNAs (lncRNAs) …

To date, the role of lncRNA long intergenic non‑protein‑coding RNA 1132 (LINC01132)
expression in epithelial ovarian cancer (EOC) has not been explored. Thus, LINC01132 …

Long noncoding RNAs (lncRNAs) are RNA molecules with a length of more than 200 nt that
have been discovered in recent years. LncRNAs can participate in regulating gene …

Long noncoding RNAs (lncRNAs) have been characterized to play an essential role in
ovarian tumorigenesis via controlling a variety of cellular processes, such as cell …